Spotlight on: Anti-obesity drugs

Following on from the success of our previous 'Spotlight' events, we're announcing a new regular webinar series, beginning with Spotlight on: Anti-obesity drugs on Tuesday 7 November.
Book here 👉 rsm.ac/3tHgLaW
Popularised within the US, semaglutide (Wegovy) has recently been approved for use by NICE. During the webinar we'll explore the detail behind different classes of anti-obesity drugs, evaluate the efficacy and safety of them, discuss the regulatory processes that oversee the approval and surveillance of these medications as well as the ethical concerns.
Each hour-long episode in the new Spotlight series will unite global experts, clinicians, and researchers for thought-provoking conversations on topical subjects in healthcare.